FIDZOC owner Contact Information online
from Millennium Pharmaceuticals, Inc.
FIDZOC
US serial number:85107379
Application filling date:Aug. 13, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Apr. 29, 2013
Publication date:Jan. 31, 2012
Abandoned date:Apr. 29, 2013
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer
Internatio
Services:Pharmaceutical preparations for human use
namely
for the treatment of hematological malignancies
cancer
auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer
Current owner owner name:Millennium Pharmaceuticals, Inc.
Current owner owner address:40 Landsdowne Street
Cambridge,
MASSACHUSETTS
UNITED STATES
02139
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:David Ehrlich
Attorney docket number:MILL 1005542
Correspondent name address:DAVID EHRLICH
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK,
NEW YORK
UNITED STATES
10017-1822
Trademark staff tm attorney:PARADEWELAI, BENJI YUE
Trademark staff law office assigned FIDZOC:LAW OFFICE 101
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Mar. 29, 2011 Nov. 16, 2010 Apr. 19, 2011 Apr. 12, 2011 Jan. 31, 2012 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
